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 Many essential oils and their components are known to have antimicrobial 
activity. However, their strong aroma, flavor, and hydrophobic nature make them difficult 
to incorporate into food products. New methods to improve antimicrobial activity at 
reduced concentrations and/or reduce the influence of food components on 
antimicrobial activity are needed. In this study, the objective was to combine the 
emulsifier soy lecithin with eugenol in an attempt to enhance the activity of the latter 
against the foodborne pathogen Escherichia coli O157:H7. 
Eugenol was added to a pH 7.2 sodium phosphate buffer (PBS), PBS with 0.03% 
(v/v) tryptic soy broth (TSB), PBS with 0.3% TSB, PBS with 0.6% TSB or PBS with 
0.9% TSB and lecithin solution (0.0025, 0.005, 0.010, or 0.015% (w/v)) and 
homogenized at 10,000 rpm for 3 min. An overnight culture of Escherichia coli O157:H7 
was added and survivors enumerated at 0, 1, 3, 6, 12, and 24 h on tryptic soy agar 
(TSA) incubated for 24 h at 37°C. The effect of varying microbiological media 
concentrations (0.03-0.09% w/v) on lecithin interaction with eugenol was also evaluated. 
In buffer with 550 ppm of eugenol, 0.01% lecithin slightly increased the 
effectiveness of eugenol (P<0.05) while 0.0025, 0.005, and 0.015% samples did not 
differ from the control. When 600 ppm of eugenol was used, the samples containing 
0.0025% and 0.015% lecithin slightly increased the antibacterial activity of eugenol 
(P<0.05) while 0.005, 0.005, and 0.010% lecithin had no significant effect (P<0.05). At 
650 ppm of eugenol, there was no significant difference (P<0.05) between the control 
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and the lecithin containing samples. In 0.03% TSB, the presence of 0.01% lecithin 
significantly increased the antibacterial activity of eugenol at both 550 and 650 ppm 
while 0.1% lecithin significantly decreased the activity. In 0.3% TSB, only minor 
differences were found while in 0.9% tryptic soy broth (TSB), the antimicrobial activity of 
eugenol was essentially eliminated except for a 1 log CFU/ml reduction in the presence 
of 0.01% (but not 0.1%) lecithin. Overall, lower concentrations of lecithin improved the 
antimicrobial properties of eugenol when media concentrations were low indicating 
interactions between the lecithin, eugenol and microbiological media.  
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CHAPTER I  
INTRODUCTION 
 Foodborne illnesses remain a major issue across the United States despite 
advances in food safety and processing technologies. The Centers for Disease Control 
and Prevention report that 1 in 6 Americans suffer from a food related illness every year 
(62). One potential method for improving food safety would be to add antimicrobials to 
foods to prevent growth of or inactivate foodborne pathogens. While consumers 
demand safe and wholesome foods, their acceptance of traditional antimicrobials is 
declining.  As a result, the food industry as a whole is increasingly seeking out label-
friendly antimicrobials. A potential solution for the food industry lies in the use of 
antimicrobials that come from natural sources and do not need to be labeled as 
synthetic chemical preservatives (75).  
 Essential oils (EOs) and their components are known to have antimicrobial 
properties and are considered natural which may be appealing to consumers. Their 
Generally Recognized as Safe (GRAS) classification makes them desirable to food 
manufacturers. Because of these properties, EOs have the potential to serve as novel 
antimicrobial preservatives in food industry. However, in many cases a high 
concentration, usually over 500 ppm, of the EOs or EO components are needed to 
inhibit foodborne pathogens (18). These relatively high concentrations make them 
unsuitable for use in many food products due to strong flavor and aroma characteristics. 
If the antimicrobial activity of EOs and EO components can be increased, use in the 




Eugenol, an EO component of cloves is known to have broad spectrum 
antibacterial properties. It has been shown by some research that EOs in emulsions 
may have better activity in foods than free EOs. For example, in a previous study, Li 
(46) found that the antimicrobial activity of eugenol against Escherichia coli O157:H7 
was increased in the presence of certain concentrations of lecithin. The inactivation rate 
as measured by D-value (time to decrease the viable population by 90%) in the 
presence of eugenol decreased from ca. 4.0 min to 1.2 min in the presence of 0.0025% 
(w/v) lecithin (46). What made the study unique was that at concentrations above 
0.0025% lecithin, the D-value increased indicating the potential for an optimum level of 
lecithin for inactivation. The purpose of the present study was to further investigate if the 
addition of the emulsifier, soy lecithin, to eugenol was could serve to stabilize the 
emulsion and increase the antibacterial activity of free eugenol.  
The objectives of this study were (1) to determine whether the previous results 
could be replicated, and (2) what effect time of exposure, lecithin concentration, and 
concentration of microbiological media had on the antibacterial activity of eugenol 
against E. coli O157:H7.   
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CHAPTER II  
LITERATURE REVIEW 
Escherichia coli O157:H7  
Background  
Escherichia coli are Gram-negative, rod-shaped bacteria that ferment lactose 
with the production of gas in 48 h at 35°C making them members of the coliform group 
of bacteria as well as Enterobacteriaceae. There exist strains of E. coli that are 
pathogenic or non-pathogenic. The pathogenic types are enteropathogenic (EPEC), 
enterotoxigenic (ETEC), enteroinvasive (EIEC), enteroaggregative (EAEC) and 
enterohemorrhagic (EHEC). Serotype Escherichia coli O157:H7 was the first EHEC 
recognized as a foodborne pathogen when it was isolated in 1982 from four patients in 
Oregon and Michigan who had eaten undercooked meat from a fast food restaurant 
chain (49, 60).  
The optimum growth temperature for this bacteria is 37°C with an upper limit of 
44 to 45°C and a minimum of 8°C (40). It grows well at pH 5.5 to 7.5 but the growth rate 
declines heavily at lower pH values with a minimum growth pH between pH 4 and 4.5 
(16, 17). In food products under the minimum growth pH, E. coli O157:H7 can survive 
for weeks or months with increased survival in refrigeration temperatures (15). 
Cattle are a common reservoir of E. coli O157:H7 (74). Young cows more 
frequently carry the bacterial than adult animals. A survey of cattle herds in the United 
States found an incidence rate of 3.2% among dairy calves (74). The E. coli population 
being shed by the calves was between <102 and 105 CFU/g (15). E. coli O157:H7 is 
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found inside the gastrointestinal tract of cattle, particularly in the fore stomachs, distal 
ileum, proximal cecum, spinal colon, and descending colon (15). Transmission to 
humans is most commonly associated with raw beef and milk, but it has been identified 
in a multitude of different food products including fruit, vegetables, juice, and water (24, 
49, 68) 
Pathogenesis 
E. coli’s ability to produce Shiga toxins greatly contributes to its ability to cause 
disease (47).  Both Shiga toxin 1 and 2 are produced by E. coli O157:H7 but Shiga toxin 
2 is more often associated with severe illness (48). This toxin can lead to hemolytic 
uremic syndrome, hemorrhagic colitis, kidney damage, and death in severe cases (28, 
48). The toxin passes through the epithelium of the intestines and disrupts the epithelial 
cells which line the blood vessels that connect to the kidneys (69). Illness can occur 
between 1 and 8 days after exposure with an average incubation period of 3 days (49). 
Symptoms can include diarrhea, vomiting, fever, abdominal pain (49, 67).   
Outbreaks 
 E. coli O157:H7 is the most commonly isolated enterohemorrhagic serotype of E. 
coli in several countries including the United States (47). It is estimated that E. coli 
O157:H7 infections cause 63,000 illnesses and 20 deaths in the United States annually 
(62). These infections cost an estimated 255 million dollars annually in 2009 dollars 
(38). While the annual number of Salmonella and Campylobacter cases exceed the 
number of E. coli O157:H7 cases annually, the fatality rates and hospitality rates of E. 
coli are much higher (47).  
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 Since 2011, there have been 6 multistate outbreaks of E. coli O157:H7 reported 
by the Centers for Disease Control (11). In 2014, a four state outbreak was traced to a 
Detroit meat packing plant and caused sickness in at least 12 people in four states (3, 
10). Of the 12 confirmed cases, all reported eating a hamburger at a restaurant and 8 
stated that they had eaten an undercooked hamburger, rare or medium-rare, days 
before symptoms began (3). In 2013, an outbreak associated with ready-to eat salads 
infected at least 33 people in four states (9). Romaine lettuce was determined to be the 
cause of the outbreak and it was believed the lettuce became contaminated at the farm 
level through wind transfer or from contaminated farm equipment (2). In 2012, 33 
infections were reported in 5 states (8). This outbreak was traced to a single producer 
but the cause of the contamination is not known (8). In 2011, three multistate outbreaks 
were reported. The first involved 60 people in 10 states who were affected by an 
outbreak traced to romaine lettuce (6). The second outbreak affected 14 people in 5 
states and was traced to store bought bologna (5). The third multistate outbreak in 2011 
involved 8 people in 3 states and was caused by in-shell hazelnuts (7). 
Control Measures 
Apple cider and other fruit juices are have been associated with E. coli O157:H7 
infections due to the high acid resistance and low infectious dose of E. coli (44). This 
pathogen is also able to survive for long periods of time in refrigeration temperatures 
(73). Juices can become contaminated due to contact with contaminated soil, water, or 
employees. The Food and Drug Association has a 5-Log Reduction Performance 
Standard in place for fruit and vegetable juices. According to this standard, juice 
products must be treated so that the population of the pertinent pathogen, frequently 
6 
 
Escherichia coli O157:H7, is reduced by 5 logs in order to comply with the Hazard 
Analysis and Critical Control Point (HACCP) requirements (4).  
Heat treatment is often used to control E. coli O157:H7 in food products. This 
includes pasteurization of liquid products and cooking of solid products to a temperature 
of 68.3˚C for 15 seconds (42). However, heat treatment is not an option for all food 
products and may actually reduce the nutritional quality and flavor of some products 
such as apple cider (44). Additionally, pasteurization processing and materials are also 
very expensive. Therefore, non-thermal methods of control could be very beneficial to 
the food industry. 
Essential Oils 
Background 
 Spices are defined as aromatic or fragrant plant products which can be used to 
impact flavor, aroma, or color to food products (22, 37). Herbs are generally defined as 
leaves and flowering portions of soft-stemmed plants which are used to season food 
products (22). Typically, herbs and spices are obtained from the fruit, seeds, rhizomes, 
roots, leaves, bark, flower, or bulb portion of a plant (22). The principal flavoring 
components of spices are essential oils (58).  
Properties   
Essential oils are defined as oily liquids which are obtained from aromatic plant 
materials (18). Each oil can contain 20 to 60 components in various concentrations with 
two or three components typically found in high concentrations, between 20 and 70%, 
and the rest being found in trace amounts (12). The major components of essential oils 
are generally divided into four categories based on their chemical structures. These 
7 
 
categories are terpenes, terpenoids, phenylpropenes, and other (39). Terpenes are 
primarily responsible for the aroma of essential oils and consist of 5 carbon isoprene 
units (1, 39). Terpenoids are partially responsible for the flavor and aroma 
characteristics of essential oils and they consist of repeating branched five carbon units 
with an isopentance skeleton (54). Phenylpropenes have a six carbon aromatic phenol 
group (39). Essential oils are produced by plants to provide protection from 
microorganisms and insects and are extracted from several different areas of plants 
including leaves, bark, flowers, and seeds (51, 57). 
Many essential oil components have been shown to have antibacterial and 
antifungal properties. The antimicrobial activity of these components is heavily 
influenced by their hydrophobicity which improves their ability to solubilize and disrupt 
the phospholipid bilayers of cytoplasmic membranes (45). The structure of essential oil 
compounds greatly impacts its ability to disrupt cytoplasmic membranes. The presence 
of a free -OH group in essential oil compounds, such as carvacrol and thymol, is 
believed to contribute to the EOs ability to disrupt the cytoplasmic membrane (45). 
Eugenol’s hydroxyl group is believed to bind to and interact with proteins (39). In 
eugenol, EO components such as phenolic alcohol, aldehydes, or ketones are also 
effective antibacterial agents (45). Phenolic compounds have the ability to disrupt the 
cytoplasmic membrane, proton motive force, electron flow, and active transport (18). 
Phenolic compounds may also cause a microorganism to alter its fatty acid or 
phospholipid composition in the cytoplasmic membrane which may result in a disruption 
in nucleic acid synthesis, nutrient uptake, and electron transport (25).  
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In general, Gram-negative bacteria are less susceptible to EOs than Gram-
positive bacteria (30). This is due to the presence of lipopolysaccharides in the outer 
cell membrane which, because of their hydrophilic nature, provide an increased 
tolerance for hydrophobic compounds such as those found in essential oils (39, 52).  
Extraction Methods 
Essential oils can be extracted from plants by several different methods including 
steam distillation, solvent extraction, and supercritical fluid extraction (13). Steam 
distillation is the most commonly used commercial method. In this method, selected 
parts of the plant are heated with hot water or steam. The heat causes the cell 
structures to break down and releases the essential oils which are volatilized and 
collected via distillation (70). Solvent extraction is more often used for delicate flower 
materials or fragile plant components which are not resistant to heat or steam treatment 
(70). For this process, acetone, hexane, petroleum ether, methanol, or ethanol is added 
to the selected plant material and it is heated to extract the essential oil. The 
temperature for this process varies by technique with the accelerated solvent extraction 
technique requiring temperatures ranging from 50 to 180°C (41). The filtrate is then 
concentrated using solvent evaporation. Alcohol is mixed with the concentrate and the 
mixture is distilled at a low temperature which allows the alcohol to absorb the fragrance 
(70). When the alcohol evaporates, the absolute oil remains (70). To perform 
supercritical carbon dioxide extraction, carbon dioxide is exposed to high-pressure, 
about 72 bar, which causes it to take a liquid form (41). Supercritical carbon dioxide is 
useful because it can penetrate cellular matrices to extract the EO components which 
are very soluble in it (41, 70). When this is complete, the pressure is returned to normal 
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atmospheric conditions, around 1 bar, and the carbon dioxide then reverts to its gas 
form and evaporates leaving the essential oil compounds (41, 70). Carbon dioxide is a 
good solvent for this extraction because it has a low toxicity, is easy to separate from 
the extracted compounds, and has a low cost (34, 76). 
Use in Food Industry 
EOs are primarily used in the food industry to add desirable flavors and/or 
aromas to food products (53). US FDA regulations classify these compounds as 
generally recognized as safe (GRAS) for use in foods. Because they are GRAS and are 
considered “natural” additives, the food industry has great interest in EOs for uses other 
than their contribution to flavors, such as use as antimicrobials and antioxidants. This is 
because of a growing consumer demand for food products with “less processing” and 
more “natural” ingredients (61). Thus, EOs have been investigated and actually applied 
as food preservatives due to their antibacterial and antifungal capabilities (23, 53).   
Eugenol as an Antimicrobial Compound 
Properties  
Eugenol (Figure 1) belongs to the phenylpropanoid class of compounds. It is the 
major component of several oils including allspice, basil, and clove and makes up 
approximately 84% of clove EO and 72% of cinnamon leaf EO (20, 51). This oily 
substance is typically a clear or pale yellow color (71). Eugenol has a molecular weight 
of 164.2 and is partially hydrophobic (31, 43). 
Antibacterial Activity 
Eugenol is a particularly effective essential oil against foodborne pathogens such 
as E. coli due to the amount of phenolic compounds it possesses. It has the ability to 
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penetrate the cellular membranes of bacteria and cause ATP and potassium to leak 
from the cell (32, 35, 39, 72). It has been found to inhibit amylase and protease 
production in Bacillus cereus and contributed to the deterioration of the cell wall and the 
inhibition of enzyme activity in Enterobacter aerogenes (71). The antimicrobial activity of 
eugenol against the Gram-negative bacteria Proteus mirabilis is due to its ability to bind 
to the cytoplasmic membrane of the bacterium and make it more permeable (27). 
Additionally, eugenol can cause pores to form in the plasma membrane of bacteria 
which causes intracellular proteins to be released (27).  
Sensory Characteristics 
Essential oils are frequently used in the food industry to impart flavor and aroma 
characteristics to food products (39). The concentration of essential oils required to act 
as preservative agents in food, however, is much higher. In order to achieve 
antimicrobial activity in food products, concentrations over 500 ppm must be used for 
many products (18, 66). At that concentration, however, major changes to the sensory 
characteristics of food products will likely make the product unacceptable to consumers. 
In a recent study, the tolerance limit for carvacrol, thyme, and rosemary essential oils 
was found to be 20 ppm or less when tested on a hedonic scale in tomato juice and 
vegetable juice (29). Many spice components, including eugenol, contribute a bitter or 
pungent taste to food (36). 
Enhancing Antimicrobial Effectiveness of Eugenol and other EO components 
EO components, while effective against a variety of bacteria, are difficult to 
incorporate into food products. This is due to their hydrophobic nature and because of 
the complex nature of food. EO components may react with hydrophobic food 
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components which reduces their activity. Because of this, a high concentration of EO or 
EO components is required which may lead to potential sensory problems. Therefore, 
the effectiveness of EOs must be increased so that a lower, and more commercially 
acceptable, amount can be used. The use of limiting intrinsic and/or extrinsic factors for 
foods along with reduced concentration EO treatments could potentially be used as 
preservation hurdle technologies. These limiting factors may include pH, temperature, 
atmosphere, combinations of EO components or and the use of compounds such as 
emulsifiers to enhance antimicrobial activity. Hurdle technology is the combination of 
two or more preservation parameters which creates maximum control against 
microorganisms while preserving the sensory characteristics of the product (64). 
One potential method to enhance EO effectiveness is to adjust the pH of the 
environment. The effectiveness of essential oil components in different pH 
environments has been evaluated. Several essential oils and components were tested 
at pH 7.2, 4 and 4.5. The minimum inhibitory concentration (MIC) of eugenol was 0.05% 
v/v against E. coli O157:H7 at pH 7.2. When the pH was reduced to 4.5, the MIC 
decreased to 0.025% and at pH 4 the MIC was reduced to <0.0031% v/v. Additionally, 
the minimum bactericidal concentration at pH 7.2 was 0.1% and was decreased to 0.05 
at pH 4 (55). Temperature may also contribute to the effectiveness of EOs. EOs were 
found to be more effective at room temperature in one study due to the changes in 
membrane fluidity (59). At low temperatures, the phospholipids in the membrane are 
more closely packed together forming a rigid gel structure. At higher temperatures, the 
phospholipids are less tightly packed and the membrane has a liquid-crystalline 
structure (59). Combinations of essential oil components have increased the 
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antibacterial effects against some microorganisms. The minimal inhibitory concentration 
against E. coli CGMCC 1.487 was decreased form approximately 1600 ppm to 400 ppm 
when treated with a combination of cinnamaldehyde, thymol, or carvacrol (56). 
The inclusion of emulsifiers on the activity of EOs has been evaluated 
extensively, either for their potential enhancement or for producing water soluble micro- 
or nanoparticles. In one study, researchers combined EOs with lecithin and agar 
stabilizers. When 0.25% (w/v) lecithin was tested in combination with oregano oil and 
thyme oil, the antibacterial properties of the EOs against E. coli O157:H7 was greatly 
reduced. It was proposed by the authors that the lecithin interfered with the ability of the 
essential oils to physically interact with the cells of the bacteria (19). When combined 
with 0.05% agar, the antibacterial properties of EOs was significantly increased. 
Researchers believe this is due to less rapid separation of the essential oil components 
from the water phase or because the ability of the essential oil component to interact 
with the phospholipids in the outer layer of the bacteria was neutralized by the additional 
presence of phospholipids in lecithin (19).  
Lecithin 
Background  
 Lecithin (Figure 2) is widely used in the food industry as an emulsifier, wetting 
agent, release agent, anti-spatter agent, and phosphate dispersant (65). It contains a 
mixture of phospholipids including phosphatidylcholine, phosphatidylethanolamine, 
phosphatidylinositol, phosphatidic acid, phosphatidyl serine, and lysophosphatides  
  Lecithin can be produced from many sources of living matter including plant, 
animal, and microbial sources (63). It was first derived from egg yolk but it is now more 
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commonly recovered from plant sources including cottonseed, peanuts, sunflower 
seeds, sesame seeds, flax seed, and soybeans (21). For commercial use, lecithin 
derived from vegetable oil, primarily soybeans, is the most common (21).Soybean 
lecithin, on average, contains about 35% soybean oil, 18% phosphatidylcholine, 15% 
phosphatidylethanolamine, 11% phosphatidylinositol, 9% other phosphatides, and 12 % 
carbohydrates (50). Commercial soybean lecithin is typically obtained as a by-product of 
vegetable oil production. Several methods can be used to extract lecithin from soybeans 
including hydraulic pressing, screw pressing, prepress solvent extraction, and direct 
solvent extraction (21).   
Use in Food Industry 
Lecithin obtained from vegetable sources has GRAS regulatory status in the 
United States (63). With modification, lecithin can be used in both oil-in-water and 
water-in-oil emulsions (26). The emulsification properties of lecithin are largely due to 
the presence of phospholipids, the main component of lecithin. These phospholipids are 
partly hydrophobic (non-polar) and partly hydrophilic (polar) (33). The hydrophilic portion 
is soluble in water while the hydrophobic portion is soluble in oil (14). To create an 
emulsion, the emulsifier orients at the boundary between two immiscible liquids with the 
hydrophobic portion in the oil phase and the hydrophilic portion in the water phase (14) 






MATERIALS AND METHODS 
Bacterial Strain 
 E. coli O157:H7 strain ATCC 43889 was obtained from the Department of Food 
Science at the University of Tennessee. This was grown in tryptic soy broth (TSB; Difco, 
Sparks, MD) at 37°C for 24 h, combined with glycerol, and kept at 0°C. Working cultures 
were created by inoculating 10 ml of TSB and incubating for 24 h at 37°C. 
Eugenol-Lecithin Preparations 
Eugenol (4-allyl-2-methoxyphenol, 99%) was obtained from Acros Organics 
(Fairlawn, NJ) and lecithin (soybean lecithin, >99%) was obtained from Fisher Scientific 
(Fairlawn, NJ). 
To replicate the original experiments on which this study was based, the 
concentration of eugenol was 800 ppm, the concentrations of lecithin used ranged from  
0.001 to 0.015% w/v, the suspension medium was 0.5% TSB (based upon carryover of 
medium from the culture), and the time of exposure was 0 to 30 min. 
For the initial experiments, (0.5% w/v TSB), lecithin concentrations ranged from 
0.001% w/v to 0.015% w/v. Lecithin was added to 0.1M sodium phosphate buffer (pH 
7.2) which had been sterilized at 121°C for 15 min using an autoclave. The lecithin in 
buffer mixture was stirred continuously while heating to boiling (ca. 100°C) for 5 min to 
dissolve the lecithin. Distilled water was added to the solution to replace the water lost 
during boiling (about 3% of total volume). To prepare emulsions, 800 ppm eugenol was 
added to stock lecithin buffer solutions in 125 ml Erlenmeyer flasks and samples were 
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then homogenized at 10,000 rpm using a Polytron PY 10/35 homogenizer (Kinematica, 
Inc., Bohemia New York) for 3 min at room temperature (46).  
For the next set of experiments in 0.03%, 0.3%, 0.6% and 0.9% (w/v) TSB, 
lecithin was added at concentrations ranging from 0.001% w/v to 0.015% w/v. Lecithin 
was added to 0.1M sodium phosphate buffer (pH 7.2) which had been sterilized at 
121°C for 15 min using an autoclave. The lecithin in buffer mixture was stirred 
continuously while heating to boiling (ca. 100°C) for 5 min to dissolve the lecithin. 
Distilled water was added to the solution to replace the water lost during boiling (about 
3% of total volume). To prepare emulsions, 550, 600 or 650 ppm eugenol was added to 
stock lecithin buffer solutions in 125 ml Erlenmeyer flasks and samples were then 
homogenized at 10,000 rpm using a homogenizer (Polytron, Kinematica) for 3 min (46).  
Inactivation Experiments 
A 24 h culture of E. coli O157 that had been grown at 37°C was then added to 
each flask containing eugenol-lecithin mixtures. Flasks were incubated statically at 25°C 
and a sample was removed from each flask at 0, 1, 3, 6, 12, and 24 h to enumerate E. 
coli O157. Samples were serially diluted using 0.1% peptone water (Difco) and spread 
plated in duplicate on tryptic soy agar (TSA; Difco). TSA plates were incubated for 24 h 
at 37°C and the log CFU/ml was calculated for each sample.  
 For samples containing 0.03% w/v media, 99 ml of the lecithin, eugenol, and 
phosphate buffer solution were added to a flask and 1 ml of an overnight (24 h) culture 
of E. coli O157:H7 was added. For samples containing 0.3% w/v media, 90 ml of the 
lecithin, eugenol, and phosphate buffer solution was added to the flask and 10 ml of an 
overnight (24 h) culture of E. coli O157:H7 was added. For samples containing 0.6% 
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w/v media, 80 ml of the lecithin, eugenol, and phosphate buffer solution was added to 
the flask and 10 ml of an overnight (24 h) culture of E. coli O157:H7 was added. Then 
10 ml of sterile TSB broth was added. For samples containing 0.9% w/v media, 70 ml of 
the lecithin, eugenol, and phosphate buffer solution was added to the flask and 10 ml of 
an overnight (24 h) culture of E. coli O157:H7 was added. Then 20 ml of sterile TSB 
broth was added.  
Effect of Time 
In the present experiments, the maximum incubation times evaluated initially 
were 30 min but were lengthened to 24 h for subsequent experiments. 
Statistics 
 Each experiment was repeated three times. Analysis of variance was conducted 
using version 9.4 of Statistical Analysis Software. Least significant differences were 




RESULTS AND DISCUSSION 
In initial testing, 800 ppm of eugenol was combined with 0 to 0.015% lecithin in 
buffer containing 0.03% TSB and E. coli O157:H7 was exposed for 30 min (Fig. 3). 
Lecithin (0.001, 0.0025, 0.005, 0.005, and 0.015% w/v) did have a significant effect on 
increasing the activity of eugenol compared to the control (P< 0.05) after 30 min but 
reductions were only ca. 1 log CFU/ml. The concentration of lecithin did not appear to 
have any relationship to the extent of inhibition as was reported in a previous study 
where 0.0025% lecithin was found to be an “optimum” level for inactivation (46). Since 
the findings of Li (46) could not be replicated, the effect of eugenol and lecithin 
concentrations, time, and microbial media concentration were investigated further.  
The first thing evaluated was the antimicrobial effect of lecithin itself. The addition 
of soy lecithin alone (0.0025 to 0.015%) in 0.3% TSB had no antimicrobial effect on E. 
coli O157:H7 after 24 h (P<0.05) (Fig. 4). There also was no significant reduction 
(P<0.05) in the population of E .coli O157:H7 after 24 h in the control buffer. 
Next the effects of varying concentrations of eugenol (550-650 ppm) and the 
presence of microbiological medium (0.03-0.9%) in the phosphate buffer on the 
antimicrobial activity against E. coli O157:H7 was determined (Fig. 5-7). In the 
experiments performed by Li (46), 10 ml of an overnight E. coli culture in TSB was 
added to 45 ml of lecithin and phosphate buffer solution. This resulted in a total TSB 
concentration of 0.5% w/v in each sample. In order to determine whether 
microbiological media concentration had an effect on the antibacterial properties of 
eugenol and lecithin, 0.03% w/v, 0.3% w/v, 0.6% w/v, and 0.6% w/v media were added 
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to the lecithin-eugenol mixtures and the inactivation experiment was repeated. At 550 
ppm eugenol, there was no reduction (< 1 log CFU/ml) in viable E. coli O157:H7 nor any 
significant differences between 0.6 and 0.9% media (P<0.05) (Fig. 5). When the media 
concentration was reduced to 0.3%, E. coli O157:H7 was significantly lower (P<0.05) 
than 0.6 and 0.9% media but the average log reduction was only 1.72 log CFU/ml. At 
0.03% media, a smaller volume of culture reduced the initial count by 1 log but the 
reduction after 24 h was much greater at ca. 4.9 log CFU/ml compared to 0.6 and 0.9%. 
Similarly to 550 ppm, at 600 ppm eugenol there was no reduction (< 1 log CFU/ml) in 
viable E. coli O157:H7 nor any significant differences between 0.6 and 0.9% media (Fig. 
6). When the media concentration was reduced to 0.3%, E. coli O157:H7 counts were 
significantly lower (P<0.05) than 0.6 and 0.9% media with an average log reduction of 
1.83 log CFU/ml. At 0.03% media, a smaller volume of culture reduced the initial count 
by 1 log. After 24 h of incubation there was a very large decrease in viable counts of ca. 
7 log CFU/ml compared to the 0.6 and 0.9% media. At 650 ppm eugenol, there was no 
reduction (< 1 log CFU/ml) in viable E. coli O157:H7 nor any significant differences 
between 0.6 and 0.9% media (Fig. 7). When the media concentration was reduced to 
0.3%, E. coli O157:H7 showed an average log reduction of 4.8 log CFU/ml which was 
significantly lower (P<0.05) than 0.6 and 0.9% media. At 0.03% media, the reduction 
after 24 h was ca. 7 log CFU/ml compared to 0.6 and 0.9% media. Overall, it was 
evident that TSB had significantly negative effect on the antimicrobial activity of eugenol 
against E. coli O157:H7. 
 Next, the interactive effects of varying concentrations of eugenol (550, 600, and 
650 ppm) with lecithin (0.0025, 0.005, 0.01, and 0.015% w/v) in phosphate buffer on the 
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antimicrobial activity of eugenol against E. coli O157:H7 was determined (Fig. 8-10). At 
550 ppm eugenol, there was no significant difference between 0.0025, 0.005, and 
0.015% lecithin compared to 0% lecithin (Fig. 8). All showed an average of 1.7 log 
CFU/ml reduction (P<0.05). When the lecithin concentration was 0.010% w/v, E. coli 
O157:H7 counts were significantly lower (P<0.05) with an average reduction of 3.07 log 
CFU/ml after 24 h. At 600 ppm, there was no significant difference in viable E. coli 
O157:H7 counts between 0.005 and 0.01% lecithin compared to 0% lecithin (1.8 log 
CFU/ml reduction) (P<0.05) (Fig. 9). At 0.0025 and 0.015% w/v lecithin, E. coli counts 
were significantly lower (P<0.025) than 0% lecithin with an average log reductions of 
2.80 log CFU/ml and 3.51 log CFU/ml, respectively, after 24 h. 650 ppm eugenol with 
no lecithin was lethal to the E. coli O157:H7 with a reduction of nearly 5 log CFU/ml 
after 24 h (Fig. 10). The addition of soy lecithin (0.0025, 0.005, 0.010, and 0.015% w/v) 
had no additional antimicrobial effect on E. coli O157:H7 and, in fact, 0.0025% was 
antagonistic. Therefore, while higher concentrations of eugenol caused greater 
reduction of viable E. coli O157:H7, the lecithin either had no effect or the effect was not 
related to concentration.  
The influence of media concentration on interaction between eugenol and lecithin 
was evaluated by reducing the concentration of TSB to 0.03%. Eugenol was tested at 
550 or 650 ppm and lecithin was tested at 0.01 or 0.1% w/v (Fig.11-12). With 550 ppm 
eugenol and no lecithin, the reduction in viable counts of ca. 4 log CFU/ml after 24 h in 
0.03% TSB (Fig. 11) was much larger than that the 1.5 log CFU/ml reduction after 24 h 
seen in 0.3% TSB (Fig. 8). When the lecithin concentration was 0.1% w/v, viable E. coli 
O157:H7 were significantly higher (P<0.05) than the 0% lecithin control with an average 
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log reduction of ca. 2.3 log CFU/ml. When the lecithin concentration was reduced to 
0.01%, at 24 h viable cells of E. coli O157:H7 were significantly reduced by an average 
6.73 log CFU/ml compared to time 0 which was significantly lower (P<0.05) than 0% 
lecithin. Increasing the eugenol concentration to 650 ppm enhanced inactivation under 
all test conditions compared to 550 ppm but the pattern was very similar with 0.01% 
lecithin dramatically increasing the inactivation of eugenol while 0.1% had an 
antagonistic effect (Fig. 12). With 0.1% w/v lecithin, E. coli O157:H7 counts were 
significantly higher (P<0.05) than 0% lecithin at 24 h. After 24 h, the populations of E. 
coli O157:H7 in both the 0% and 0.01% lecithin samples were below the detection limit 
of 1 log CFU/ml. Thus, it was again evident that TSB concentration had a very large 
impact on the antimicrobial activity of eugenol and lecithin with higher concentrations 
reducing activity. In addition, at lower TSB concentrations, higher concentrations of 
lecithin negatively impacted eugenol antimicrobial activity against E. coli O157:H7. This 
was further confirmed by evaluating the compounds in 0.9% TSB (Fig. 13-14). Here the 
effect of 550 or 650 ppm eugenol 0.01 or 0.1% lecithin were evaluated for their 
antimicrobial activity against E. coli O157:H7.  As with 0.3% media (Fig. 8), neither 550 
ppm eugenol alone or in combination with either concentration of soy lecithin had any 
antimicrobial effect on E. coli O157:H7 after 24 h (P<0.05) (Fig. 13). Similarly, at 650 
ppm eugenol had no antimicrobial activity on E. coli O157:H7 after 24 h by itself nor with 
addition of 0.1% w/v lecithin (P<0.05) (Fig. 14). When the concentration of lecithin was 
decreased to 0.01% w/v, viable E. coli O157:H7 was significantly reduced (P<0.05) 
compared to the 0 and 0.1% lecithin with an average log reduction of 1.45 log CFU/ml. 
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Overall, a reduction of the antimicrobial activity of eugenol in the presence of 
0.1% lecithin was consistent with the findings of Burt and Reinders (19). They showed 
that the addition of 0.25% lecithin greatly reduced the antibacterial properties of 
oregano, thyme oil light and thyme oil red against E. coli  O157:H7 (19). This reduction 
was likely due to the lecithin physically impeding contact of the oil with the bacteria or 
because the EO activity against the phospholipids in the bacterial cell membrane was 
limited due to the interaction of the EO with the phospholipids present in soy lecithin 
(19). 
It was apparent that media concentration affected the antimicrobial activity of the 
eugenol and the eugenol-lecithin combinations. For example, 0.01% lecithin significantly 
reduced the effectiveness of eugenol in the presence of 0.9% media, had almost no 
effect in the 0.3% media samples, and significantly increased the effectiveness of 
eugenol in 0.03% media after 24 h. Based on the results of this study, enhancement of 
eugenol antimicrobial activity against E. coli O157:H7 by an optimum concentration of 
lecithin was demonstrated as was reported by Li (46). This may be due to differences in 
TSB lots. As it was demonstrated in the present study, microbiological medium 
concentration has a large influence on the antimicrobial activity of eugenol and lecithin, 
and differences in the media could affect the interaction of lecithin and eugenol. 
Additionally, differences in the E. coli culture handling and errors measuring such small 






The ability of soy lecithin to enhance the antimicrobial activity of eugenol appears 
to be dependent on media concentration of the sample. In low media conditions, 0.01% 
lecithin greatly increased the antibacterial activity. Therefore, lecithin is a promoter of 
eugenol activity in limited situations. This is likely due to lecithin increasing the stability 
of the emulsion which can slow the separation of the oil and the water phase and 
improve the ability of eugenol to inhibit E. coli (19). In order to improve effectiveness, 
the use of lecithin may be combined with other treatments to further increase the 
antibacterial properties of essential oils.  
Tryptic soy broth was found to have a significant effect on the antimicrobial 
activity of eugenol and lecithin. Further studies should therefore determine how the 
structure and nutrient availability of food products affects the effectiveness of eugenol 
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Figure 1 Structural Formula of Eugenol (from Hyldgaard and others (40)) 
  
 









Figure 3 Average log population of E. coli O157:H7 with 0.5% w/v media, 800 ppm of eugenol, and varying lecithin 



































Figure 4 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying 

































Figure 5 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying 








































Figure 6 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying 






































Figure 7 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying 





































Figure 8 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying 












































Figure 9 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying 





































Figure 10 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying 






































Figure 11 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying 




































Figure 12 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying 





































Figure 13 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying 


























































Figure 14 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying 
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